Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Iron Oxide MR Contrast Agents For Molecular And Cellular Imaging

J. Bulte, D. Kraitchman
Published 2004 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Molecular and cellular MR imaging is a rapidly growing field that aims to visualize targeted macromolecules or cells in living organisms. In order to provide a different signal intensity of the target, gadolinium‐based MR contrast agents can be employed although they suffer from an inherent high threshold of detectability. Superparamagnetic iron oxide (SPIO) particles can be detected at micromolar concentrations of iron, and offer sufficient sensitivity for T2(*)‐weighted imaging. Over the past two decades, biocompatible particles have been linked to specific ligands for molecular imaging. However, due to their relatively large size and clearance by the reticuloendothelial system (RES), widespread biomedical molecular applications have yet to be implemented and few studies have been reproduced between different laboratories. SPIO‐based cellular imaging, on the other hand, has now become an established technique to label and detect the cells of interest. Imaging of macrophage activity was the initial and still is the most significant application, in particular for tumor staging of the liver and lymph nodes, with several products either approved or in clinical trials. The ability to now also label non‐phagocytic cells in culture using derivatized particles, followed by transplantation or transfusion in living organisms, has led to an active research interest to monitor the cellular biodistribution in vivo including cell migration and trafficking. While most of these studies to date have been mere of the ‘proof‐of‐principle’ type, further exploitation of this technique will be aimed at obtaining a deeper insight into the dynamics of in vivo cell biology, including lymphocyte trafficking, and at monitoring therapies that are based on the use of stem cells and progenitors. Copyright © 2004 John Wiley & Sons, Ltd.
This paper references
10.1016/0730-725X(86)91045-3
Immunospecific NMR contrast agents.
P. Renshaw (1986)
10.1016/S0306-4522(02)00696-6
Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into the adult rat striatum
R. L. Zhang (2003)
10.1002/NBM.925
Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis
Lisa Kostura (2004)
10.1002/mrm.10465
Receptor‐mediated endocytosis of iron‐oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging
E. Ahrens (2003)
10.1016/S0730-725X(99)00085-5
Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents.
J. Sipe (1999)
10.1097/01.rli.0000101027.57021.28
Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10
I. Raynal (2004)
10.1182/BLOOD-2004-01-0328
Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease.
B. Anderson (2004)
10.1038/nm1101-1241
Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent
M. Zhao (2001)
A simple method for coupling proteins to insoluble polysaccharides.
C. Sanderson (1971)
10.1148/RADIOL.2283020322
Targeting of hematopoietic progenitor cells with MR contrast agents.
H. Daldrup-Link (2003)
10.1182/BLOOD-2002-12-3669
Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells.
K. A. Hinds (2003)
10.1148/RADIOLOGY.182.2.1732953
Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging.
R. Weissleder (1992)
10.1002/mrm.10585
Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles
P. Jendelová (2003)
10.1038/SJ.NEO.7900266
MRI of transgene expression: correlation to therapeutic gene expression.
T. Ichikawa (2002)
10.1073/PNAS.93.10.4897
Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers.
J. Kukowska-Latallo (1996)
10.1002/MRM.1910030218
Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen
M. Helena Mendonca Dias (1986)
10.1021/BC980125H
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.
L. Josephson (1999)
10.1002/JMRI.1880040343
Magnetoferritin: Characterization of a novel superparamagnetic MR contrast agent
J. Bulte (1994)
10.1161/01.CIR.0000084537.66419.7A
Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells
J. D. Hill (2003)
10.1002/MRM.1910330209
In Vivo Dynamic MRI Tracking of Rat T‐Cells Labeled with Superparamagnetic Iron‐Oxide Particles
T. Yeh (1995)
10.1021/BC0255236
Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake.
M. Zhao (2002)
10.1073/pnas.242435499
Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat
M. Hoehn (2002)
10.1148/RADIOL.2211001784
Human transferrin receptor gene as a marker gene for MR imaging.
A. Moore (2001)
10.1006/exnr.1993.1085
Nuclear Magnetic Resonance (NMR) Imaging of Iron Oxide-Labeled Neural Transplants
N. Hawrylak (1993)
10.1073/PNAS.97.26.14268
Ultrasensitive magnetic biosensor for homogeneous immunoassay.
Y. Chemla (2000)
10.1073/PNAS.96.26.15256
Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination.
J. Bulte (1999)
10.1002/ana.10467
Magnetic resonance imaging and neurosphere therapy of stroke in rat
Z. Zhang (2003)
10.1016/S1076-6332(03)80271-4
Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents.
J. Frank (2002)
10.1097/00001756-199912160-00043
Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain.
R. Franklin (1999)
10.1002/mrm.10480
Macrophage infiltration into the rat knee detected by MRI in a model of antigen‐induced arthritis
N. Beckmann (2003)
10.1021/CM010125I
Synthesis and Characterization of Soluble Iron Oxide−Dendrimer Composites
E. Strable (2001)
10.1073/PNAS.76.7.3392
Iron-dextran antibody conjugates: General method for simultaneous staining of two components in high-resolution immunoelectron microscopy.
A. Dutton (1979)
10.1056/NEJMOA022749
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
M. Harisinghani (2003)
10.1002/mrm.10511
MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain
J. Bulte (2003)
In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.
M. Kircher (2003)
10.1002/jnr.10693
Tracking superparamagnetic iron oxide labeled monocytes in brain by high‐field magnetic resonance imaging
M. Zelivyanskaya (2003)
10.1002/(SICI)1097-0215(19980209)75:4<626::AID-IJC22>3.0.CO;2-5
Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti‐epidermal growth factor receptor antibody
Toshikazu Suwa (1998)
10.1161/01.CIR.0000012425.71261.FC
Catheter-Based Endomyocardial Injection With Real-Time Magnetic Resonance Imaging
R. Lederman (2002)
10.1002/mrm.10387
Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation
N. Beckmann (2003)
10.1148/RADIOLOGY.191.1.8134576
MR lymphography: study of a high-efficiency lymphotrophic agent.
R. Weissleder (1994)
10.1002/jmri.1194
Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles
S. A. Schmitz (2001)
10.1002/mrm.20086
MR‐trackable intramyocardial injection catheter
P. Karmarkar (2004)
10.1002/mrm.10541
MRI‐based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE
M. Rausch (2003)
10.1097/00004424-199206000-00009
Magnetic resonance imaging of abscesses using lipid-coated iron oxide particles.
T. Chan (1992)
10.1097/01.WCB.0000090505.76664.DB
in Vivo Monitoring of Macrophage Infiltration in Experimental Ischemic Brain Lesions by Magnetic Resonance Imaging
C. Kleinschnitz (2003)
10.1148/RADIOLOGY.168.2.3393649
Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
David D. Stark (1988)
10.2144/98244RR01
Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies.
U. Schoepf (1998)
10.1073/PNAS.0403918101
MRI detection of single particles for cellular imaging.
E. Shapiro (2004)
10.1002/mrm.10417
Imaging single mammalian cells with a 1.5 T clinical MRI scanner
Paula Foster-Gareau (2003)
10.1046/J.1523-1755.2000.00286.X
Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration.
Y. Zhang (2000)
10.1161/01.CIR.0000055323.57885.88
Superparamagnetic Iron Oxide–Based Method for Quantifying Recruitment of Monocytes to Mouse Atherosclerotic Lesions In Vivo: Enhancement by Tissue Necrosis Factor-&agr;, Interleukin-1&bgr;, and Interferon-&ggr;
S. Litovsky (2003)
10.1021/JA036409G
Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media.
J. M. Pérez (2003)
10.1161/01.CIR.0000070931.62772.4E
In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction
D. Kraitchman (2003)
10.1002/JMRI.1880070629
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
A. Moore (1997)
10.1002/glia.10159
Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis
T. Ben-Hur (2003)
10.1126/SCIENCE.284.5411.143
Multilineage potential of adult human mesenchymal stem cells.
M. Pittenger (1999)
10.1002/mrm.10556
Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition
H. Kalish (2003)
10.1002/(SICI)1097-4547(19980601)52:5<549::AID-JNR7>3.0.CO;2-C
Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: Early histopathological correlation
S. Xu (1998)
10.1021/BC000018Z
High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model.
Z. Zhang (2000)
10.1002/MRM.1910120202
Monoclonal antibody‐coated magnetite particles as contrast agents in magnetic resonance imaging of tumors
S. Cerdán (1989)
10.1016/S0142-9612(02)00440-4
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating.
C. Wilhelm (2003)
10.1148/RADIOLOGY.181.1.1887040
Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging.
R. Weissleder (1991)
10.1038/73219
In vivo magnetic resonance imaging of transgene expression
R. Weissleder (2000)
10.1021/BC960003U
Magnetically labeled secretin retains receptor affinity to pancreas acinar cells.
T. Shen (1996)
10.1038/nbt720
Magnetic relaxation switches capable of sensing molecular interactions
J. M. Pérez (2002)
10.3727/000000003108747352
Improved Efficacy of Stem Cell Labeling for Magnetic Resonance Imaging Studies by the Use of Cationic Liposomes
E. J. van den Bos (2003)
10.1182/BLOOD-2004-06-2222
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model.
S. Anderson (2005)
10.1002/mrm.10110
MRI of insulitis in autoimmune diabetes
A. Moore (2002)
10.1161/HC3401.093148
Macrophage Accumulation Associated With Rat Cardiac Allograft Rejection Detected by Magnetic Resonance Imaging With Ultrasmall Superparamagnetic Iron Oxide Particles
S. Kanno (2001)
10.1021/BC00023A007
Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging.
L. Tiefenauer (1993)
10.1002/1521-3773(20010903)40:17<3204::AID-ANIE3204>3.0.CO;2-H
Magnetic Nanosensors for the Detection of Oligonucleotide Sequences.
L. Josephson (2001)
10.1002/JMRI.1880070140
Magnetically labeled cells can be detected by MR imaging
R. Weissleder (1997)
10.1002/mrm.10418
Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imaging
C. Billotey (2003)
10.1016/S1076-6332(05)80064-9
Initial assessment of magnetoferritin biokinetics and proton relaxation enhancement in rats.
J. Bulte (1995)
10.1038/312162A0
Transferrin receptor on endothelium of brain capillaries
W. Jefferies (1984)
10.1002/mrm.10684
Noninvasive monitoring of stem cell transfer for muscle disorders
G. Walter (2004)
10.1126/SCIENCE.1090585
Molecular Imaging: Looking at Problems, Seeing Solutions
H. Herschman (2003)
10.1067/MTC.2000.110184
A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection.
S. Kanno (2000)
10.1002/MRM.1910290108
Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles
J. Bulte (1993)
10.1002/MRM.1910250115
Specific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles
Jeff W. M. Bulte (1992)
10.1002/ana.20066
Magnetic resonance imaging of labeled T‐cells in a mouse model of multiple sclerosis
S. Anderson (2004)
10.1021/LA0257337
Interaction of Anionic Superparamagnetic Nanoparticles with Cells: Kinetic Analyses of Membrane Adsorption and Subsequent Internalization
C. Wilhelm (2002)
10.1016/S0006-3495(99)77182-1
Detection of single mammalian cells by high-resolution magnetic resonance imaging.
S. J. Dodd (1999)
10.1002/(SICI)1522-2594(199902)41:2<329::AID-MRM17>3.0.CO;2-Z
In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance
V. Dousset (1999)
10.1016/0730-725X(95)02106-4
In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI.
L. Tiefenauer (1996)
10.1161/01.CIR.103.3.415
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits
S. Ruehm (2001)
10.1021/NL034983K
Peroxidase Substrate Nanosensors for MR Imaging
J. M. Pérez (2004)
10.1002/mrm.1290
Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage
M. Rausch (2001)
10.1016/0730-725X(86)90054-8
Ferromagnetic particles as contrast agent in T2 NMR imaging
M. Olsson (1986)
10.1002/(SICI)1522-2594(199901)41:1<156::AID-MRM22>3.0.CO;2-C
MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome
O. Hauger (1999)
10.1046/J.1523-1755.2003.00048.X
Detection of inflammation following renal ischemia by magnetic resonance imaging.
Sang-Kyung Jo (2003)
10.1016/S1076-6332(96)80564-2
Tagging of T cells with superparamagnetic iron oxide: uptake kinetics and relaxometry.
J. Bulte (1996)
10.1021/BC9600630
In vitro gene delivery by degraded polyamidoamine dendrimers.
M. X. Tang (1996)
10.1016/S0167-4889(98)00002-0
Measuring transferrin receptor gene expression by NMR imaging.
A. Moore (1998)
10.1002/NBM.770
In‐vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO
M. Rausch (2002)
Magnetic resonance molecular imaging of the HER-2/neu receptor.
D. Artemov (2003)
10.1126/SCIENCE.1636086
Magnetoferritin: in vitro synthesis of a novel magnetic protein.
F. Meldrum (1992)
10.1016/0006-8993(92)91135-2
Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent
A. Norman (1992)
10.1097/01.TP.0000090164.42732.47
Superparamagnetic iron oxide particles transactivator protein-fluorescein isothiocyanate particle labeling for in vivo magnetic resonance imaging detection of cell migration: uptake and durability
C. Kaufman (2003)
10.1148/RADIOLOGY.179.2.2014305
Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging.
E. Seneterre (1991)
10.1148/RADIOLOGY.177.3.2243978
Receptor imaging: application to MR imaging of liver cancer.
P. Reimer (1990)
10.1002/MRM.1910030205
Ferromagnetic contrast agents: A new approach
P. Renshaw (1986)
10.1038/74464
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
M. Lewin (2000)
10.1016/0730-725X(90)90143-P
A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent.
L. Josephson (1990)
10.1002/MRM.1910400209
Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways
M. Kresse (1998)
10.1007/s00249-003-0312-0
Deformation of intracellular endosomes under a magnetic field
C. Wilhelm (2003)
10.1148/RADIOL.2281020638
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
J. Frank (2003)
MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.
L. G. Remsen (1996)
Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis.
V. Dousset (1999)
10.1148/RADIOL.2293021215
Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
A. Arbab (2003)
10.1158/0008-5472.CAN-03-2798
Novel Nanosensors for Rapid Analysis of Telomerase Activity
J. Grimm (2004)
10.1016/J.IJPHARM.2003.09.042
The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture.
C. Berry (2004)
10.1148/RADIOLOGY.175.2.2326475
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
R. Weissleder (1990)
10.1016/j.expneurol.2004.02.007
In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord
I. Lee (2004)
10.1161/01.CIR.0000068315.98705.CC
Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging
M. E. Kooi (2003)
10.1038/nbt1201-1141
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
J. Bulte (2001)
10.1148/RADIOLOGY.217.3.R00DC04819
Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model.
O. Hauger (2000)
10.1016/0730-725X(93)90074-N
MION-ASF: biokinetics of an MR receptor agent.
B. Schaffer (1993)
10.1002/mrm.10529
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging
Y. Wadghiri (2003)
10.1148/RADIOLOGY.193.3.7972790
Liver MR imaging with iron oxides: toward consensus and clinical practice.
R. Weissleder (1994)
10.1016/S0022-1759(01)00433-1
Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles.
C. H. Dodd (2001)
10.1002/MRM.1910300513
Intracellular labeling of T‐cells with superparamagnetic contrast agents
T. Yeh (1993)
10.1148/RADIOLOGY.193.2.7972773
Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging.
P. Reimer (1994)



This paper is referenced by
In vitro internalization of moldey ion Rhodamine B in ovine mesenchymal stem cell: A comparative study
R. Gnanadevi (2019)
10.1161/ATVBAHA.112.255224
Visualization of Vascular Inflammation in the Atherosclerotic Mouse by Ultrasmall Superparamagnetic Iron Oxide Vascular Cell Adhesion Molecule-1–Specific Nanoparticles
Marta Michalska (2012)
10.1039/b820593k
Targeting exofacial protein thiols with Gd(III) complexes. An efficient procedure for MRI cell labelling.
G. Digilio (2009)
10.1533/9781908818744.151
Future scenarios: nanoparticles and stem cells
Gerardo Caruso (2015)
10.1016/j.foodchem.2014.04.022
Dynamic light scattering-based method to determine primary particle size of iron oxide nanoparticles in simulated gastrointestinal fluid.
Seungchul Yang (2014)
10.1007/s00330-008-1262-9
Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver
A. Luciani (2008)
Theoretical and Computational Generalizations of Magnetic Nanoparticle Hyperthermia Including Optimization , Control , and Aggregation
Caleb M. Koch (2014)
10.1016/J.MATLET.2013.01.134
Gd-complex labeled magnetite nanoparticles as fluorescent and targeted magnetic resonance imaging contrast agent
Y. Li (2013)
10.1002/nbm.1664
Exploiting the tumor microenvironment for theranostic imaging
Ioannis Stasinopoulos (2011)
10.2217/nnm.11.14
Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.
H. Fattahi (2011)
10.1007/s12265-011-9281-3
Imaging Cardiac Stem Cell Therapy: Translations to Human Clinical Studies
W. Zhang (2011)
10.1021/bc200111p
Biologically optimized nanosized molecules and particles: more than just size.
M. Longmire (2011)
10.1016/J.SCRIPTAMAT.2017.07.005
The effect of Al substitution on the structural and magnetic properties of epitaxial thin films of epsilon ferrite
L. Corbellini (2017)
10.1007/978-3-642-12945-2_12
Small Animal Magnetic Resonance Imaging: Basic Principles, Instrumentation and Practical Issue
P. Jakob (2011)
10.1039/C0JM02660C
NIR-emitting fluorescent gold nanoclusters doped in silica nanoparticles
X. Guével (2011)
10.1007/1-4020-4384-8_18
Molecular Agents for Targeted Imaging and Therapy
H. Grüll (2006)
10.1002/CMMI.104
Single-cell detection by gradient echo 9.4 T MRI: a parametric study.
P. Smirnov (2006)
10.1007/s10856-010-4227-x
Magnetic resonance imaging probes for labeling of chondrocyte cells
Gang Liu (2011)
10.1007/s11051-012-1282-x
A mathematical model of superparamagnetic iron oxide nanoparticle magnetic behavior to guide the design of novel nanomaterials
R. Ortega (2012)
Intracellular MRI Contrast Agents for High Magnetic Fields
J. Rosenberg (2011)
10.1039/b924061f
Fabrication and characterization of magnetic mesoporous silica nanospheres covalently bonded with europium complex.
J. Feng (2010)
10.1088/0957-4484/21/15/155101
Magnetic carbon nanotube labelling for haematopoietic stem/progenitor cell tracking.
H. Gul (2010)
10.1148/radiol.09090657
MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans.
A. Nchimi (2010)
10.3892/ijmm.2014.1970
Feasibility of lentiviral‑mediated sodium iodide symporter gene delivery for the efficient monitoring of bone marrow‑derived mesenchymal stem cell transplantation and survival.
S. Shi (2014)
10.1155/2016/9240652
Stem Cell Imaging: Tools to Improve Cell Delivery and Viability
Junxin Wang (2016)
Synthesis and Application of Polymer Stabilized, Water Dispersible Copper Based Nanoparticles as Anti-cancer and Diagnostic Agents
Sriramakrishna Yarabarla (2017)
10.1039/c4ob02433h
Regulating exocytosis of nanoparticles via host-guest chemistry.
Chaekyu Kim (2015)
10.1088/0957-4484/22/24/245604
Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
F. Hu (2011)
10.1002/ADFM.200600560
Antibody‐Functionalized Hybrid Superparamagnetic Nanoparticles
M. Arruebo (2007)
10.1002/smll.201904960
Janus Magnetic-Plasmonic Nanoparticles for Magnetically Guided and Thermally Activated Cancer Therapy.
A. Espinosa (2020)
10.1016/S1773-2247(13)50005-0
Polymersomes for theranostics
J. Thévenot (2013)
10.1016/j.biomaterials.2011.12.046
The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model.
F. Dilnawaz (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar